tm logo
FEMCHECK
Live/Registered
REGISTERED

on 02 Nov 2021

Last Applicant/ Owned by

Creative Diagnostic Research LaboratoryMassey University, Drysdale Drive

Palmerston North

NZ

4474

Serial Number

79299178 filed on 26th May 2020

Registration Number

6541669 registered on 02th Nov 2021

in the Principal Register

Correspondent Address

Kazuyo Morita

Kazuyo Morita

P.O. Box 8749

Attn: Trademark Docketing

Denver, CO 80201

Filing Basis

No Filing Basis

Disclaimer

NO DATA

FEMCHECK

Non-prescription, over the counter, diagnostic in vitro test kits for home use in the field of fertility monitoring, namely kits comprised of medical diagnostic reagents and assays to monitor urinary metabolites in particular estrogen metabolites, progesterone metabolites, cortisol metabolites and testosterone metabolites, and to quantitate urinary based assays to monitor ovulation and ovarian act Read More

Classification Information


Class [005]
Pharmaceutical Products


Non-prescription, over the counter, diagnostic in vitro test kits for home use in the field of fertility monitoring, namely kits comprised of medical diagnostic reagents and assays to monitor urinary metabolites in particular estrogen metabolites, progesterone metabolites, cortisol metabolites and testosterone metabolites, and to quantitate urinary based assays to monitor ovulation and ovarian activity, to identify ovulation dates and to identify fertility periods of females; chemical diagnostic reagents and assays for medical purposes for use in diagnostic in vitro test kits for home use in the field of fertility monitoring, namely medical diagnostic reagents and assays to monitor urinary metabolites in particular estrogen metabolites, progesterone metabolites, cortisol metabolites and testosterone metabolites, to track ovulation and ovarian activity, to identify ovulation dates and to identify fertility periods of females

Class [009]
Computer & Software Products & Electrical & Scientific Products


Downloadable software and downloadable mobile applications for use with non-prescription, over the counter, diagnostic in vitro test kits for home use in the field of fertility monitoring in particular with kits comprised of medical diagnostic reagents and assays to monitor urinary metabolites in particular estrogen metabolites, progesterone metabolites, cortisol metabolites and testosterone metabolites, and to quantitate urinary based assays to monitor ovulation and ovarian activity, to identify ovulation dates and to identify fertility periods of females; Downloadable software and downloadable mobile applications for testing and tracking urinary metabolites, in particular estrogen metabolites, progesterone metabolites, cortisol metabolites and testosterone metabolites, to monitor ovulation and ovarian activity, to identify ovulation dates and to identify fertility periods of females

Class [035]
Advertising, Business & Retail Services


Retail and wholesale store services for non-prescription, over the counter, diagnostic in vitro test kits for home use in the field of fertility monitoring, namely kits comprised of medical diagnostic reagents and assays to monitor urinary metabolites in particular estrogen metabolites, progesterone metabolites, cortisol metabolites and testosterone metabolites, and to quantitate urinary based assays to monitor ovulation and ovarian activity, to identify ovulation dates and to identify fertility periods of females; retail and wholesale store services for chemical diagnostic reagents and assays for medical purposes for use in diagnostic in vitro test kits for home use in the field of fertility monitoring, namely medical diagnostic reagents and assays to monitor urinary metabolites in particular estrogen metabolites, progesterone metabolites, cortisol metabolites and testosterone metabolites, to track ovulation and ovarian activity, to identify ovulation dates and to identify fertility periods of females; retail and wholesale store services for downloadable software and downloadable mobile applications for use with non-prescription, over the counter, diagnostic in vitro test kits for home use in the field of fertility monitoring, namely kits comprised of medical diagnostic reagents and assays to monitor urinary metabolites in particular estrogen metabolites, progesterone metabolites, cortisol metabolites and testosterone metabolites, and to quantitate urinary based assays to monitor ovulation and ovarian activity, to identify ovulation dates and to identify fertility periods of females; retail and wholesale store services for downloadable software and downloadable mobile applications for testing and tracking urinary metabolites, in particular estrogen metabolites, progesterone metabolites, cortisol metabolites and testosterone metabolites, to monitor ovulation and ovarian activity, to identify ovulation dates and to identify fertility periods of females; retail and wholesale store services for software as a service (SAAS) services featuring software for use with non-prescription, over the counter, diagnostic in vitro test kits for home use in the field of fertility monitoring, namely kits comprised of medical diagnostic reagents and assays to monitor urinary metabolites in particular estrogen metabolites, progesterone metabolites, cortisol metabolites and testosterone metabolites, and to quantitate urinary based assays to monitor ovulation and ovarian activity, to identify ovulation dates and to identify fertility periods of females; retail and wholesale store services for software as a service (SAAS) services for testing and tracking urinary metabolites, in particular estrogen metabolites, progesterone metabolites, cortisol metabolites and testosterone metabolites, to monitor ovulation and ovarian activity, to identify ovulation dates and to identify fertility periods of females; online advertising and marketing services in relation to the aforementioned goods

Class [042]
Computer & Software Services & Scientific Services


Software as a service (SAAS) services featuring software for use with non-prescription, over the counter, diagnostic in vitro test kits for home use in the field of fertility monitoring in particular with kits comprised of medical diagnostic reagents and assays to monitor urinary metabolites in particular estrogen metabolites, progesterone metabolites, cortisol metabolites and testosterone metabolites, and to quantitate urinary based assays to monitor ovulation and ovarian activity, to identify ovulation dates and to identify fertility periods of females; software as a service (SAAS) services featuring software for testing and tracking urinary metabolites, in particular estrogen metabolites, progesterone metabolites, cortisol metabolites and testosterone metabolites, to monitor ovulation and ovarian activity, to identify ovulation dates and to identify fertility periods of females; providing temporary use of online non-downloadable computer software for use with non-prescription, over the counter, diagnostic in vitro test kits for home use in the field of fertility monitoring in particular with kits comprised of medical diagnostic reagents and assays to monitor urinary metabolites in particular estrogen metabolites, progesterone metabolites, cortisol metabolites and testosterone metabolites, and to quantitate urinary based assays to monitor ovulation and ovarian activity, to identify ovulation dates and to identify fertility periods of females; providing temporary use of online non-downloadable computer software for testing and tracking urinary metabolites, in particular estrogen metabolites, progesterone metabolites, cortisol metabolites and testosterone metabolites, to monitor ovulation and ovarian activity, to identify ovulation dates and to identify fertility periods of females

Mark Details


Serial Number

No 79299178

Mark Type

No Service Mark

Attorney Docket Number

No 112862.0001

44D Filed

No

44D Current

No

44E filed

No

44E Current

No

66A Filed

No

66A Current

No

Current Basis

No

No Basis

No

Legal History


Show more

Status DateAction Taken
02th Feb 2022FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
02th Nov 2021REGISTERED-PRINCIPAL REGISTER
17th Aug 2021OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
17th Aug 2021PUBLISHED FOR OPPOSITION
15th Aug 2021NOTIFICATION PROCESSED BY IB
28th Jul 2021NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
28th Jul 2021NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
28th Jul 2021NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
13th Jul 2021APPROVED FOR PUB - PRINCIPAL REGISTER
13th Jul 2021EXAMINER'S AMENDMENT ENTERED